Suggestions
Adam Fraser
Chief Financial Officer at Omniscient Neurotechnology (o8t)
Adam Fraser is the Chief Financial Officer (CFO) at Omniscient Neurotechnology (o8t), a role he has held since May 2021. He is responsible for overseeing the company's financial operations and strategic financial planning. In April 2023, he also took on the position of Chief Operating Officer, where he manages day-to-day operations and strategic initiatives at the company, which specializes in brain mapping technology leveraging data science and AI.12
Career Overview
Adam Fraser has over 25 years of experience in finance, corporate finance, private equity, and technology. His career includes notable positions:
- CFO and Strategy at Mortgage Choice (2003-2007): Managed financial strategies and corporate finance operations.
- Associate Director at Allco Finance Group (2007-2009): Oversaw significant financial operations.
- Co-founder of an Online Retail Start-Up (2009): Entered the entrepreneurial space focusing on e-commerce.
- CFO and COO at PLAUT IT Australia (2011-2019): Directed operational and financial activities for an IT service provider.
- Director of Business Transformation at EY (2019-2021): Led initiatives to drive efficiency and growth.12
Education
Adam holds a Bachelor of Arts with Honors in Economics from the University of Nottingham and has completed several professional certifications, including:
- ACA Certification from ICAEW
- Graduate Diploma in Applied Finance from the Securities Institute Australia
- General Manager Program at AGSM @ UNSW Business School.12
Contributions to Omniscient Neurotechnology
Under his leadership, Omniscient Neurotechnology has achieved significant milestones, including FDA clearance for its MRI-based functional brain analysis technology in 2022 and recognition at industry events such as the SRS Shark Tank 2024.1 The company is known for its innovative approach to understanding brain networks, which aids in diagnosing and treating neurological conditions.3
Adam Fraser's extensive background in finance and technology positions him as a key player in advancing the company's mission to revolutionize brain care.